Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 9CNS 5Genitourinary 4Gastrointestinal 4Thoracic 2Gynecologic 2Breast 2Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 2Neoplasms 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Breast Neoplasms, Male 1Brain Neoplasms 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
epothilone B × Breast × Clear all
NCT00035126 2017-02-08

EPO906 Therapy in Patients With Advanced Breast Cancer

Novartis

Phase 2 Completed
46 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT00450866 2014-02-28

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Case Comprehensive Cancer Center

Phase 2 Completed
55 enrolled 12 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡